Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells (Q38955079)
Jump to navigation
Jump to search
scientific article published on 15 September 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells |
scientific article published on 15 September 2016 |
Statements
1 reference
Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells (English)
1 reference
1 reference
Toshiko Kamata
1 reference
Akane Suzuki
1 reference
Naoko Mise
1 reference
Fumie Ihara
1 reference
Mariko Takami
1 reference
Yuji Makita
1 reference
Atsushi Horinaka
1 reference
Kazuaki Harada
1 reference
Naoki Kunii
1 reference
Shigetoshi Yoshida
1 reference
Ichiro Yoshino
1 reference
Shinichiro Motohashi
1 reference
15 September 2016
1 reference
1 reference
15 September 2016
1 reference
1 reference
1 reference
Identifiers
1 reference